Inotiv Inc reports results for the quarter ended March 31 - Earnings Summary

• Inotiv Inc NOTV.OQ reported a quarterly adjusted loss of 44 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-1.86. The mean expectation of three analysts for the quarter was for a loss of 63 cents per share. Wall Street expected results to range from -68 cents to -59 cents per share.

• Revenue rose 4.4% to $124.32 million from a year ago; analysts expected $123.96 million.

• Inotiv Inc's reported EPS for the quarter was a loss of 44 cents​.

• The company reported a quarterly loss of $14.89 million.

• Inotiv Inc shares had fallen by 20.4% this quarter and lost 57.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.6% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Inotiv Inc is $6.00

This summary was machine generated from LSEG data May 7 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)